Storys zum Thema Enterprises

04.11.2008 – 22:16
ICS Copper Systems Ltd
ICS Pauses for Strategic Review
Abbotsford, Canada, November 4 (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) announces that due to the reduction in copper prices over the last few months and current market conditions the Company has decided to suspend it's exploration activities and the completion of it's EMEW plant in Zambia as it undertakes a strategic review of operations. Mokambo Review To date the company has completed a first phase drilling programme on the Mokambo sulphide ...
mehr
04.11.2008 – 12:36
Burcon NutraScience Corporation
Burcon Announces Technology Breakthrough - Introduces New CLARISOY(TM) - Soy Protein Isolate
Vancouver, Canada, November 4 (ots/PRNewswire) - Burcon NutraScience Corporation (TSX-V: BU) announces today that it has developed a revolutionary soy protein isolate. Burcon has branded this new soy protein isolate as CLARISOY(TM). CLARISOY(TM) is 100% soluble and transparent in acidic solutions, enabling applications down to pH 2.5. CLARISOY(TM) also ...
mehr
04.11.2008 – 09:36
Tata Communications
Tata Communications Strengthens MPLS Footprint in South East Asia
Mumbai, India, November 4 (ots/PRNewswire) - - South East Asia is a Key Focus for Network Expansion Tata Communications, a leading provider of the new world of communications, today announced the expansion of its global MPLS (Multi- Protocol Label Switching) services into key South - East Asian destinations, including the Philippines, Malaysia, Taiwan, and Thailand - providing rest of the world connectivity to ...
mehr
03.11.2008 – 15:07
Asset Control International
Citadel Solutions Implements Asset Control to Support its Growing Customer Base
New York, November 3 (ots/PRNewswire) - - Asset Control's AC Plus Streamlines Data Capture and Standardizes Distribution Asset Control, a world-wide leader in financial data management solutions, today announced that Citadel Solutions LLC, a wholly-owned independent subsidiary of Citadel Investment Group, LLC, has implemented Asset Control's AC Plus data ...
mehr
01.11.2008 – 13:06
Roche Pharmaceuticals
Renewed Hope for a Cure: Extending Pegasys Treatment to 72 Weeks Provides New Treatment Option for Difficult-to-Treat Hepatitis C Patients
Basel, Switzerland, November 1 (ots/PRNewswire) - - Three New Studies Presented at AASLD Demonstrate Efficacy and Safety of Extended Treatment in Non-Responders, Relapsers and Slow-Responders Cure rates for certain groups of difficult-to-treat hepatitis C patients can be improved significantly by ...
mehr
01.11.2008 – 13:05
Roche Pharmaceuticals
New Study Shows That Pegasys Regimen Provides Higher Cure Rates for Hepatitis C Patients
Basel, Switzerland, November 1 (ots/PRNewswire) - A new, independently-conducted study being presented at AASLD shows that PEGASYS(R) (peginterferon alfa-2a (40KD)) regimens result in higher cure rates for hepatitis C patients compared to regimens with another pegylated interferon.(1) Comparing Today's Standard Treatment Regimens: The Milan Safety Tolerability ...
mehr

31.10.2008 – 14:15
Boehringer Ingelheim
Largest Study of its Kind Reveals Low Sexual Desire is Most Common Female Sexual Problem
Ingelheim, Germany (ots/PRNewswire) - - 1 in 10 Women Experience Distress Associated With the Most Common Form of Female Sexual Dysfunction, yet the Condition Remains Largely Under-Recognised and Under-Diagnosed - For non-US media only Results from the PRESIDE*(1) survey, the largest study assessing the prevalence of female sexual problems, show that ...
mehr
31.10.2008 – 11:53
LINK Financial
LINK Financial Forms GBP250 Million Partnership
London (ots/PRNewswire) - LINK Financial ("LINK"), the leading European purchaser and servicer of performing and non-performing consumer receivables, today announces the formation of a GBP250 million partnership with one of the world's largest pension funds based in Europe. The agreement initially covers a co-investment in a portfolio of UK distressed loans that has been acquired by LINK from a global consumer lender ...
mehr
30.10.2008 – 15:52
MTV
The Beatles Inspire New Music Video Game; Apple Corps Ltd., MTV and Harmonix Come Together for Unprecedented Deal
New York (ots/PRNewswire) - - Exclusive Agreement Set to Bring The Beatles Music to Fans for the First Time in Interactive Form Here, There and Everywhere in 2009 The Beatles' extraordinary music and phenomenal legacy is set to rock across the universe in the form of a video game through an exclusive ...
mehr
30.10.2008 – 13:13
CEVA Logistics
CEVA Group Plc Announces the Release of its Quarter 3 - 2008 Results
Hoofddorp, Netherlands (ots/PRNewswire) - CEVA Group Plc will release its Quarter 3 2008 results on November 4, 2008. The Interim Financial Statements will be published on CEVA's website (http://www.cevalogistics.com) at 09:00 Central European Time. A press release with the highlights of the Report will be issued on the same date. CEVA. Making Business Flow ...
mehr
29.10.2008 – 14:03
Merck Serono
Merck Serono's US Affiliate EMD Serono, Inc. and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Geneva, Switzerland (ots/PRNewswire) - - Merck Serono's US Affiliate EMD Serono, Inc. to Acquire Rights in Tesamorelin, a Phase 3 Compound Being Investigated for the Treatment of Excess Abdominal Fat in HIV Patients With Lipodystrophy in the US - Merck KGaA, Darmstadt, Germany, of Which Merck Serono is ...
mehr
28.10.2008 – 14:53
Therapure Biopharma Inc.
Therapure Biopharma Inc. Announces Collaboration With Induce Biologics Inc.
Toronto, Canada (ots/PRNewswire) - - Ontario Biotech Companies Work Together on Innovative Bone Protein Technology TORONTO, Canada, October 28 /PRNewswire/ -- Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Dr. Cameron Clokie, President and CEO of Induce Biologics Inc. today announced a development partnership utilizing an innovative ...
mehr

28.10.2008 – 14:00
Pershing Square Capital Management, L.P.
Pershing Square Capital Management Announces Public Presentation on Target Corporation on Wednesday, October 29, 2008
New York (ots/PRNewswire) - Pershing Square Capital Management, L.P. announced today that it will host a public presentation on Wednesday, October 29, 2008 where it will detail a potential transaction that Pershing Square believes will build long-term value for Target Corporation (NYSE: TGT) and all of its ...
mehr
28.10.2008 – 13:24
Atmel Corporation
Atmel's AT91SAM9G20 ARM Embedded MPU Wins Award From Portable Design Community
Rousset, France (ots/PRNewswire) - - Portable Design China Readers Voted the AT91SAM9G20 Best in Class for Performance and Performance & Functionality vs Cost Atmel(R) Corporation (Nasdaq: ATML) announced today that its 400 MHz AT91SAM9G20 ARM926EJ-S(TM)-based embedded microprocessor has been voted one of the five best microcontrollers by the 2008 ...
mehr
28.10.2008 – 10:13
MrTed
Ready, Set, Recruit! Talent Acquisition Leader MrTed Launches Free Applicant Tracking System
San Francisco (ots/PRNewswire) - - Game-Changing Initiative has Potential to Revolutionize ATS Market Seizing on the opportunity to help cash- and credit-strapped small and midsized businesses, MrTed Ltd., a recognized leader in talent acquisition solutions, today announced the beta availability of SmartRecruiters, a 100% free applicant tracking system (ATS) ...
mehr
28.10.2008 – 00:19
Telefónica
Telefonica Announces Extension of the Tender Offer to Acquire 100% of the Shares of Compania de Telecomunicaciones de Chile S.A.
Madrid, Spain (ots/PRNewswire) - -- The Expiration Date of the U.S. Offer has been extended until 12:00 midnight, New York City time, on October 31, 2008. Telefonica S.A. ("Telefonica") announced today that the U.S. Offer would be extended to 12:00 midnight, New York City time, on October 31, 2008. ...
mehr
27.10.2008 – 19:07
Stallergenes
Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
Antony, France (ots/PRNewswire) - Stallergenes has just obtained authorization (IND(1)) from the FDA for immediately launching a phase III clinical trial in the United States with Oralair(R) Grasses in the treatment of allergic rhinoconjunctivitis to grass pollens in adults. The aim of the study, which will ...
mehr
27.10.2008 – 16:53
Wyeth Pharmaceuticals
Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
Washington (ots/PRNewswire) - - Data presented at the joint annual meeting of ICAAC and IDSA - Results suggest candidate vaccine may be as effective as Prevnar for the seven shared serotypes, and provide expanded coverage for six additional serotypes - Wyeth on track to complete U.S. filing for ...
mehr

27.10.2008 – 13:29
Atmel Corporation
Atmel and Adeneo Announce Windows Embedded CE 6.0 Training on AT91SAM ARM9 Embedded MPUs
Rousset, France and Bellevue, Washington (ots/PRNewswire) - - From November 17 to November 21, 2008, in Dallas, TX, including free AT91SAM9261 evaluation kit. Atmel(R) Corporation (Nasdaq: ATML) and Adeneo announced today a Microsoft(R) Windows(R) Embedded CE(R) 6.0 Training Course in Dallas, TX from November 17 to November 21, 2008. This event is an ...
mehr
27.10.2008 – 13:09
Atmel Corporation
Atmel's picoPower 8/16-bit XMEGA MCU Cuts Power and Processing Requirement By 98%
Boston (ots/PRNewswire) - - Virtually eliminates context switching and interrupt usage ESC Boston, MA, Booth Number 801 -- Atmel(R) Corporation (Nasdaq: ATML) announced today its latest family of 32 MIPS, picoPower(TM) 8/16-bit microcontroller that radically improves MCU performance by off-loading interrupts and data transfers to an on-chip event manager and ...
mehr
27.10.2008 – 08:06
Wyeth Pharmaceuticals
New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
Maidenhead, England (ots/PRNewswire) - - Data From Another Study Supported the use of ENBREL for up to Five Years in Ankylosing Spondylitis Patients New safety and efficacy data for active ankylosing spondylitis (AS) patients treated with ENBREL(R) (etanercept) were presented at the American College of ...
mehr
27.10.2008 – 07:07
Roche Pharmaceuticals
MabThera Continues to Improve Patient Response in Rheumatoid Arthritis With Multiple Courses of Treatment
Basel, Switzerland (ots/PRNewswire) - - MabThera Shown to be Effective and Well Tolerated Over the Long-Term A study(1) has shown that rheumatoid arthritis patients given multiple courses of MabThera experienced further improvements in their condition with each subsequent treatment course. The patients in ...
mehr
26.10.2008 – 13:12
Yahoo! Canada
Monica Martinez of Toronto, Canada Crowned 2008 Yahoo! Rock Paper Scissors World Champion
Toronto, Canada (ots/PRNewswire) - - Wins First Ever All-Female Championship Final Match with a Dramatic Throw of Scissors Beating Paper to Win $10,000 Grand Prize With Photo Local RPS talent prevailed when Monica Martinez, a jewelry store owner from Toronto who entered for fun, with no intention of winning, won match after match to eventually seize ...
mehr
24.10.2008 – 15:14
GenOdyssee SA
GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
Paris (ots/PRNewswire) - - GenOdyssee Has Received Notice of Allowance of European Patent Application Covering Its Core Natural Evolution Technology Invented in 2002, and Received Broad Product Applications Protection Rights to All Cytokine Families GenOdyssee (GO), a biotechnology company dedicated to ...
mehr

23.10.2008 – 18:25
sanofi-aventis Group
Sanofi-aventis is Complying With the EMEA's Recommendation to Temporarily Suspend the Marketing Authorisation of Acomplia(R) in Obese and Overweight Patients
Paris (ots/PRNewswire) - - Sanofi-aventis Will Comply With the European Authorities Request to Temporarily Suspend the Marketing Authorisation of Acomplia(R) in Obese and Overweight Patients and Will Make Every Effort to Actively Support Patients and Health Care Professionals in This Process. - ...
mehr
23.10.2008 – 17:10
Boehringer Ingelheim
Telmisartan (MICARDIS(R)) as Effective as Ramipril But With Better Long-Term Tolerability in High-Risk Cardiovascular Asian Patients
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart ...
mehr
23.10.2008 – 00:12
Atmel Corporation
Atmel's New Family of Touch Screen Solutions Enable Two Touch Gestures for Intuitive User Interfaces
San Jose, California (ots/PRNewswire) - - New Product Line also Includes First to Market Single Layer ITO Touchscreen Solutions for Single Touch Applications Atmel(R) Corporation (Nasdaq: ATML) today announced its new line of charge-transfer, capacitive touchscreen controller ICs targeted at some of the ...
mehr
22.10.2008 – 14:32
Honda Motor Co., Ltd.
Honda Demonstrates Life Saving Motorcycle Technology
London (ots/PRNewswire) - In its efforts to improve safety for everyone, especially vulnerable road users, Honda's leading motorcycle to car communication system is being demonstrated for the first time in Europe at the CAR 2 CAR Communication Consortium event taking place at the Opel Test Track in Dudenhofen, Germany, from 22-23 October 2008. (Photo: http://www.newscom.com/cgi-bin/prnh/20081022/325797 ) The ...
mehr
22.10.2008 – 12:21
Boehringer Ingelheim
Boehringer Ingelheim Broadens Oncology Pipeline With Promising New Data for Potentially First in Class Plk1 Inhibitor
Ingelheim, Germany (ots/PRNewswire) - - BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme - For non-US Healthcare Media Boehringer Ingelheim's most promising new cell cycle kinase inhibitor and potentially first-in-class compound, BI 6727, ...
mehr
21.10.2008 – 14:41
Atmel Corporation
Atmel Launches Unique Single Development Platform Development Kit for Automotive Applications
Detroit (ots/PRNewswire) - - Flexible Modular Architecture for Complete Automotive System Solutions Convergence Show -- Atmel(R) (Nasdaq: ATML) announced today the availability of its brand-new automotive development kit ATAPMxx, representing a single development platform for Atmel's current and future automotive products. The new kit provides an efficient ...
mehr

Vorherige60616263646566676869Nächste